Closed
Canadian Longitudinal Study on Aging (CLSA): Phase 4
Supports long-term aging research infrastructure
Last Update: April 21, 2026
Funding available
$ 8,700,000
Timeline
- Closing date : April 15, 2026
Location
Canada
Overview
Supports the continued operation of the Canadian Longitudinal Study on Aging for up to six years with a maximum of $8.7 million per year. It funds data collection, biomarker analysis, data governance, knowledge mobilization, outreach, training, and sustainability planning.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Increase performance through digital transformation
- Develop strategic partnerships
- Enhance an existing program
Eligible Funding
- Maximum amount : 8,700,000 $
Timeline
- Closing date : April 15, 2026
Eligible candidates
Eligible Industries
- Health care and social assistance
Location
- Canada
Legal structures
- Non-profit
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Non-profit candidates
Sector of operation
- Higher Education
- Research
- Diversity and Inclusion
Target groups
- General public
- Seniors
- Indigenous peoples
- Academia / students
Revenue structures
- All structures
Scope
- National
- International
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Continued implementation of the CLSA protocol.
- Completion of the final two waves of data collection.
- Analysis of a core set of biomarkers.
- Knowledge mobilization, communication, and outreach for CLSA data.
- Governance and sustainability planning for the CLSA platform.
Documents Needed
- Tri-agency CV
- Governance Plan
- Data Governance Plan
- Leadership Succession Plan
- Work Plan
- Training and Capacity Building Plan
- Participant Table
- SGBA Certificate
- Partner Details and Partner Letter, if applicable
- Indigenous Health Research Cultural Safety Form, if applicable
Eligibility
Who is eligible?
- Current CLSA leadership team members
- Canadian postsecondary institutions and affiliated institutions
- Hospitals, research institutes, and other non-profit health research organizations
Eligible expenses
- CLS A protocol and core biomarker activities
- Knowledge mobilization, communications, and outreach
- Data promotion and open science activities
- Operation and management of the CLSA platform
- Travel for required CIHR-led meetings, up to the stated cap
Eligible geographic areas
- Canada
Processing and Agreement
- Applications are peer reviewed under CIHR priority-driven initiative procedures.
- The review may include clarification questions or an opportunity to present the application.
- Final funding recommendations take reviewer input into account.
- Successful applicants are announced by CIHR.
- Annual and final reporting are required after funding decisions.
Additional information
- CIHR may share some application content with funding partners and Institute staff for relevance review and funding decisions.
- Applicants must use the tri-agency CV for this opportunity.
- Public-facing materials must be available in both English and French and be screen-reader accessible.
- CIHR may observe CLSA governance committees as part of its oversight role.
Contacts
Frequently Asked Questions about the Canadian Longitudinal Study on Aging (CLSA): Phase 4 Program
Here are answers to the most common questions about the Canadian Longitudinal Study on Aging (CLSA): Phase 4. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the Canadian Longitudinal Study on Aging (CLSA): Phase 4?
Supports the continued operation of the Canadian Longitudinal Study on Aging for up to six years with a maximum of $8.7 million per year. It funds data collection, biomarker analysis, data governance, knowledge mobilization, outreach, training, and sustainability planning.
How much funding can be received?
Canadian Longitudinal Study on Aging (CLSA): Phase 4 Funds up to $8,700,000 of admissible expenses.
Who is eligible for the Canadian Longitudinal Study on Aging (CLSA): Phase 4 program?
To be eligible for the Canadian Longitudinal Study on Aging (CLSA): Phase 4 program, you must:
Current CLSA leadership team member
Canadian-based independent researcher
Required team roles included
What expenses are eligible under Canadian Longitudinal Study on Aging (CLSA): Phase 4?
Continued implementation of the CLSA protocol.
Completion of the final two waves of data collection.
Analysis of a core set of biomarkers.
Knowledge mobilization, communication, and outreach for CLSA data.
Governance and sustainability planning for the CLSA platform.
Who can I contact for more information about the Canadian Longitudinal Study on Aging (CLSA): Phase 4?
You can contact Canadian Institutes of Health Research (CIHR) by email at support-soutien@cihr-irsc.gc.ca or by phone at 613-954-1968.
Where is the Canadian Longitudinal Study on Aging (CLSA): Phase 4 available?
The Canadian Longitudinal Study on Aging (CLSA): Phase 4 program is available across Canada.
Is the Canadian Longitudinal Study on Aging (CLSA): Phase 4 a grant, loan, or tax credit?
Canadian Longitudinal Study on Aging (CLSA): Phase 4 is a Other Support